TherapeuticsMD TXMD
NASDAQ TXMD
$2.06 +0.03 (+1.48%)
At close: Aug 20, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Non-cash Items (2021 - 2026)

TherapeuticsMD's (TXMD) quarterly Non-cash Items came in at $841000.0 in Q1 2026, down 37.0% YoY from $1.3 million in Q1 2025, and down 14.79% on a QoQ basis from $987000.0 in Q4 2025.

TherapeuticsMD (TXMD) Non-cash Items (2021 - 2026) Analysis & Trends

TherapeuticsMD (TXMD) has 6 years of Non-cash Items data on file, last reported at $841000.0 in Q1 2026.

  • Quarterly Non-cash Items fell 37.0% year-over-year to $841000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 38.33% YoY) and the FY2025 annual result came in at $3.1 million, down 10.77% from the prior year.
  • Non-cash Items fell to $841000.0 in Q1 2026, from $987000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $32.3 million in Q3 2022 to a low of -$18.2 million in Q4 2022.
  • A 5-year average of $19588.2 and a median of $3000.0 in 2022 frame the typical range for Non-cash Items.
  • Annual changes were most pronounced in 2023 — Non-cash Items plunged 213133.33% — and 2025, when it jumped 1117.53%.
  • Tracing TXMD's Non-cash Items over 5 years: stood at -$18.2 million in 2022, then jumped by 81.23% to -$3.4 million in 2023, then surged by 97.16% to -$97000.0 in 2024, then jumped by 1117.53% to $987000.0 in 2025, then slipped by 14.79% to $841000.0 in 2026.
  • The last three Non-cash Items figures came in at $841000.0 (Q1 2026), $987000.0 (Q4 2025), and $949000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 TherapeuticsMD 23.54 Mn 14.35 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 615,000.00
Jun 30, 2026 615,000.00
Mar 31, 2026 841,000.00
Mar 31, 2026 841,000.00
Dec 31, 2025 987,000.00
Dec 31, 2025 987,000.00
Sep 30, 2025 949,000.00
Sep 30, 2025 949,000.00
Jun 30, 2025 -164,000.00
Jun 30, 2025 -164,000.00
Mar 31, 2025 1.34 Mn
Mar 31, 2025 1.34 Mn
Dec 31, 2024 -97,000.00
Dec 31, 2024 -97,000.00
Sep 30, 2024 496,000.00
Sep 30, 2024 496,000.00
Jun 30, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Mar 31, 2024 580,000.00
Mar 31, 2024 580,000.00